Johnson & Johnson to Buy Firefly Bio for $1 Billion
Johnson & Johnson has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker’s oncology pipeline.
Connecting Global Economies
Flash News
Today’s Dylan Dreyer Says Son Calvin Preferred Nanny Over Her
How to watch Cardinals vs. Twins: TV channel and streaming options for June 13
UAE denies ‘false’ reports of fund transfer to Iran
Solawave Red Light Mask June Deals Code: Get 30% Off
How Jalen Brunson has outperformed every expectation with Knicks: ‘Gold dust’
Tesla deal makes ‘Elon’s life a little easier’
Ryan Reynolds, Michael Bublé & More Attend Canada Game
World Cup predictions: Brazil vs Morocco, Haiti vs Scotland and rest of matchday 3
Bitcoin’s price drop is forcing investors to revisit why they own it
A Guide to Mary-Kate Olsen, Ashley Olsen’s Family
Saturday, June 13, 2026